Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Civitanova Marche

4 clinical trials in Civitanova Marche, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Civitanova Marche at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Civitanova Marche

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Busulfan
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Deucrictibant
  • Sponsor:Pharvaris Netherlands B.V.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:(S)-N-(1-Deutero-1-(3-Chloro-5-Fluoro-2-((2-Methyl-4-(1-Methyl-1H-1,2,4-Triazol-5-Yl)Quinolin-8-Yloxy)Methyl)Phenyl)Ethyl)-2-(Difluoromethoxy)Acetamide
  • Sponsor:Pharvaris Netherlands B.V.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Civitanova Marche

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on Acute Myeloid Leukemia (AML) treatment, combining targeted therapy with standard chemotherapy to improve outcomes for adult patients. The studies aim to evaluate the effectiveness of treatment by monitoring minimal residual disease levels.

  • Blood cell proliferation disorders
  • Bone marrow malignancies
  • Targeted therapy approaches

Research centers on favorable and intermediate-risk AML cases, exploring new therapeutic combinations to enhance treatment efficacy.

02 Rare Diseases

Clinical investigations into hereditary angioedema (HAE) focus on developing prophylactic treatments. The research evaluates new oral medications for preventing angioedema attacks in patients with C1-Inhibitor deficiency.

  • Type I and II HAE
  • Prophylactic therapies
  • Long-term treatment safety

Studies examine multiple dosing regimens to establish optimal preventive strategies for patients with this rare genetic condition.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.